Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies
09:00am, Thursday, 27'th Jun 2024
Researchers used Chromium Single Cell products and Xenium In Situ to profile how gene expression is spatially regulated during secondary palate formation PLEASANTON, Calif., June 27, 2024 /PRNewswire/
10x Genomics: Sticking To The Plan To Avoid The Falling The Knife
08:00am, Friday, 21'st Jun 2024
10x Genomics has experienced a significant decline in share price, currently trading around $20 per share, with no bullish indicators for a potential reversal. Recent performance shows growth in total
10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
09:00am, Thursday, 20'th Jun 2024
New 5,000-plex gene panel increases plex by an order of magnitude and delivers industry-leading speed and throughput PLEASANTON, Calif. , June 20, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG
PHILADELPHIA, PA / ACCESSWIRE / June 11, 2024 / Kaskela Law LLC announces that it is investigating 10x Genomics, Inc. (NASDAQ:TXG) on behalf of the company's stockholders. The investigation seeks to d
Torex Gold Outlines Multi-Year Exploration Strategy
06:00pm, Monday, 10'th Jun 2024
Pipeline of high-quality targets systematically prioritized to unlock the full potential of Morelos (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. -
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
04:05pm, Wednesday, 29'th May 2024
New Xenium Prime 5K Pan-Tissue and Pathways panel increases plex by an order of magnitude and delivers industry-leading speed and throughput PLEASANTON, Calif. , May 29, 2024 /PRNewswire/ -- 10x Ge
Lab Instrument Industry Update - New Commercial Entrants
09:17am, Thursday, 23'rd May 2024
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h
Torex Gold Releases 2023 Responsible Gold Mining Report
06:00pm, Tuesday, 21'st May 2024
Report shines a spotlight on continued excellence in ESG performance and disclosure (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 21, 2024) -
Vizgen Announces Significant Win in Ongoing Patent Litigation Against 10x Genomics and Harvard University
08:00am, Tuesday, 07'th May 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has achieved a significant victor
Cathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough Of
01:04pm, Monday, 06'th May 2024
Betting big on the future is not easy. Investing guru Cathie Wood attempts to discern the big ideas that will shape tomorrow and acts on them by buying large tranches of stock for her Ark Invest famil
International Markets and 10x Genomics (TXG): A Deep Dive for Investors
10:11am, Monday, 06'th May 2024
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
04:05pm, Thursday, 02'nd May 2024
PLEASANTON, Calif. , May 2, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in
Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)
01:01am, Wednesday, 01'st May 2024
PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience, a leading innovator of high-precision tools for the life sciences industry, today announced that a decision in a court case has been made. The Eur
10x Genomics, Inc. (TXG) Q1 2024 Earnings Call Transcript
11:32pm, Tuesday, 30'th Apr 2024
10x Genomics, Inc. (NASDAQ:TXG ) Q1 2024 Earnings Conference Call April 30, 2024 4:30 PM ET Company Participants Cassie Corneau - Director of Investor Relations & Strategic Finance Serge Saxonov - Chi
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:31pm, Tuesday, 30'th Apr 2024
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street esti
